GAVILAX- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

gavilax- polyethylene glycol 3350 powder, for solution

preferred pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative use ask a doctor or pharmacist before use if you are taking a prescription drug when using this product you may have loose, watery, more frequent stools if pregnant or breast-feeding, ask a health professional before use.

SMOOTH LAX ORIGINAL PRESCRIPTION STRENGTH polyethylene glycol 3350 powder for solution United States - English - NLM (National Library of Medicine)

smooth lax original prescription strength polyethylene glycol 3350 powder for solution

walgreen company - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g

UP AND UP POWDERLAX- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

up and up powderlax- polyethylene glycol 3350 powder, for solution

target corporation - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative

KIRKLAND SIGNATURE LAXACLEAR ORIGINAL PRESCRIPTION STRENGTH- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

kirkland signature laxaclear original prescription strength- polyethylene glycol 3350 powder, for solution

costco wholesale company - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative

EASYLAX- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

easylax- polyethylene glycol 3350 powder, for solution

valu merchandisers company - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days

PURELAX- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

purelax- polyethylene glycol 3350 powder, for solution

cvs pharmacy - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative

LAXATIVE- polyethylene glycol 3350 powder, for solution United States - English - NLM (National Library of Medicine)

laxative- polyethylene glycol 3350 powder, for solution

chain drug consortium, llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days

NULYTELY- peg-3350, sodium chloride, sodium bicarbonate and potassium chloride powder, for solution United States - English - NLM (National Library of Medicine)

nulytely- peg-3350, sodium chloride, sodium bicarbonate and potassium chloride powder, for solution

physicians total care, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 210 g in 2 l - nulytely is indicated for bowel cleansing prior to colonoscopy. nulytely is contraindicated in patients known to be hypersensitive to any of the components. nulytely is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.

GOLYTELY- peg-3350 and electrolytes powder, for solution United States - English - NLM (National Library of Medicine)

golytely- peg-3350 and electrolytes powder, for solution

physicians total care, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium cation - unii:lyr4m0nh37), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 236 g in 2 l - golytely for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination. golytely for oral solution is contraindicated in patients known to be hypersensitive to any of the components. golytely for oral solution is contraindicated in patients with gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon or ileus.

SUFLAVE- polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution United States - English - NLM (National Library of Medicine)

suflave- polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution

braintree laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698) - suflave is indicated for the cleansing of the colon as a preparation for colonoscopy in adults. suflave is contraindicated in the following conditions: - gastrointestinal obstruction or ileus [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any ingredient in suflave  [see warnings and precautions ( 5.8)] risk summary there are no available data on the use of suflave during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride (suflave). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other ad